Ability of Blood Cell Parameters to Predict Clinical Outcomes of Nivolumab Monotherapy in Advanced Esophageal Squamous Cell Carcinoma

PURPOSE: Various blood cell parameters have been identified as predictive markers of tumor responses and the survival of patients with cancer treated with immune checkpoint inhibitors. The purpose of this study is to assess the ability of various blood cell parameters to predict therapeutic effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamai, Yoichi, Emi, Manabu, Ibuki, Yuta, Kurokawa, Tomoaki, Yoshikawa, Toru, Ohsawa, Manato, Hirohata, Ryosuke, Kitasaki, Nao, Okada, Morihito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10103711/
https://www.ncbi.nlm.nih.gov/pubmed/37065776
http://dx.doi.org/10.2147/OTT.S404926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10103711/
https://www.ncbi.nlm.nih.gov/pubmed/37065776
http://dx.doi.org/10.2147/OTT.S404926

Ejemplares similares